States Reach A $2.4B Deal With Opioid Manufacturer

In an agreement with 12 states over its advertising and product safety procedures, a former opioid manufacturer has in principle agreed to pay up to $2.4 billion as revealed by the state attorneys general Friday.

Although Allergan is now a part of AbbVie, it sold Teva Pharmaceuticals its generics subsidiary Actavis, which included its opioid medications, six years ago. According to the Pennsylvania attorney general, state and local governments will receive compensation as part of the settlement.

According to the deal, pharmaceutical corporations have agreed to pay more than $40 billion to resolve manufacturer and distributor claims relating to the opioid crisis.

The deal was concluded a few days after a comparable $4.3 billion deal with Teva Pharmaceuticals. A representative for Teva declined to comment on the circumstance.

According to the attorney general, the claims that the company Allergan, which manufactured generic opioids under the Norco and Kadian brands, minimized the risk of addiction in marketing and did not take enough measures to stop the drugs from being improperly diverted, were the subject of the settlement.

No amount of money could ever replace the lives we lost, the AG said, but the deal reached today will make it possible to pay for the initiatives required by Pennsylvania counties for our communities to recover from this disaster.

The subject of Allergan's and Teva's business methods and openness is still being discussed. California, Illinois, Iowa, Maryland, Massachusetts, North Carolina, Tennessee, Texas, Vermont, Virginia, and Wisconsin are all parties to this international pact. It will be possible for other states to join. In December, New York and Allergan reached a settlement.

Nearly the past 20 years, over 500,000 fatalities in the United States have been directly attributed to the epidemic of opioid addiction and overdose. The attorney general of North Carolina stated on Friday that until 2020, daily overdose deaths in his state will account for nine deaths.

According to the attorney general of North Carolina, no amount of money could ever make up for that kind of loss, but there is hope in recovery, and because of our ongoing efforts to hold these drug companies accountable, people all over this state are receiving the care and support they need to get well.

Johnson & Johnson, a pharmaceutical company, completed a $5 billion settlement earlier this year. AmerisourceBergen, Cardinal Health, and McKesson, three national medication delivery companies, recently signed a $21 billion deal. Purdue Pharma, the manufacturer of OxyContin, is pleading with a judge to approve a package that may involve up to $6 billion from Sackler family members.

Recent News